Cargando…
Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model
There are currently over 2.5 million breast cancer survivors in the United States and, according to the American Cancer Society, 10 to 20 percent of these women will develop recurrent breast cancer. Early detection of recurrence can avoid unnecessary radical treatment. However, self-examination or m...
Autores principales: | Hao, Wenrui, Friedman, Avner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831695/ https://www.ncbi.nlm.nih.gov/pubmed/27078836 http://dx.doi.org/10.1371/journal.pone.0153508 |
Ejemplares similares
-
Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR
por: Degryse, Bernard, et al.
Publicado: (2017) -
Integrin is on uPAR to unleash cells
por: LeBrasseur, Nicole
Publicado: (2003) -
uPAR's signaling two step
por: Leslie, Mitch
Publicado: (2007) -
uPAR directed-imaging of head-and-neck cancer
por: Baart,, Victor M., et al.
Publicado: (2017) -
uPAR: An Essential Factor for Tumor Development
por: Lv, Tao, et al.
Publicado: (2021)